New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build

New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions

ValueSet: NZ WHO eye and orbit haematolymphoid histology (5th edition)

Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-haematolymphoid-histology Version: 0.1.0
Active as of 2024-11-11 Computable Name: canshare-who5-eye-orbit-haematolymphoid-histology
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who5-eye-orbit-haematolymphoid-histology

Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition - 10. Haematolymphoid tumours) or an 'Other' value.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Generated Narrative: ValueSet canshare-who5-eye-orbit-haematolymphoid-histology

version: 1; Last updated: 2024-11-05 17:08:43+1300; Language: en-x-sctlang-23162100-0210105

  • Include codes fromhttp://snomed.info/sct where constraint = ^ 398831000210104 |New Zealand WHO classification of tumours (5th edition) eye and orbit haematolymphoid histology reference set| OR 74964007 |Other|

 

Expansion

Generated Narrative: ValueSet canshare-who5-eye-orbit-haematolymphoid-histology

version: 1; Last updated: 2024-11-05 17:08:43+1300; Language: en-x-sctlang-23162100-0210105

Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024

This value set contains 19 concepts

CodeSystemDisplay - English (English, en)
  51092000http://snomed.info/sctChronic lymphocytic leukaemia
  1172695008http://snomed.info/sctDiffuse large B cell lymphoma
  703711007http://snomed.info/sctErdheim-Chester disease
  397350003http://snomed.info/sctExtranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
  55150002http://snomed.info/sctFollicular lymphoma
  128622001http://snomed.info/sctHistiocytic neoplasm (morphology)
  128814006http://snomed.info/sctLangerhans cell sarcoma
  110450007http://snomed.info/sctLangerhans' cell histiocytosis
  314923001http://snomed.info/sctLow grade B-cell lymphoma morphology
  397353001http://snomed.info/sctLymphomatoid papulosis
  74654000http://snomed.info/sctMantle cell lymphoma
  35287006http://snomed.info/sctMyeloid sarcoma
  128805001http://snomed.info/sctNK/T-cell lymphoma, nasal and nasal-type
  74964007http://snomed.info/sctOther
  1187107005http://snomed.info/sctPlasmacytoma
  128804002http://snomed.info/sctPrimary cutaneous CD30 antigen positive T-cell lymphoproliferative disorder
  262711000210108http://snomed.info/sctPrimary diffuse large B cell lymphoma of vitreoretina
  1295376005http://snomed.info/sctRosai-Dorfman disease
  314926009http://snomed.info/sctT-cell lymphoma morphology

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code